Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/11/2018
SIETES contiene 92578 citas

 
 
 1 a 20 de 1059 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN. Pregabalin and the risk for opioid-related death: a nested case–control study . Ann Intern Med 2018:21 de agosto. [Ref.ID 102809]
3.Enlace a cita original Cita con resumen
Floyd CN, Warren JB. Opioids out of control. Br J Clin Pharmacol 2018;84:mayo. [Ref.ID 102794]
4.Tiene citas relacionadas Cita con resumen
El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, Aaron C, King A, Chang A. Characteristics of tianeptine exposures reported to the National Poison Data System — United States, 2000–2017. Morbidity and Mortality Weekly Report 2018;67:3 de agosto. [Ref.ID 102752]
5. Cita con resumen
Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Intern Med 2018;178:mayo. [Ref.ID 102740]
6.Tiene citas relacionadas Cita con resumen
Thielking M. Poison control calls spike for unapproved drug that produces opioid-like highs. STAT Daily Recap 2018:2 de agosto. [Ref.ID 102737]
7. Cita con resumen
8. Cita con resumen
Anónimo. Study shows that nearly half of overdose deaths are from fentanyl. DIA Daily 2018:3. [Ref.ID 102704]
9.Enlace a cita original Cita con resumen
Throckmorton DC, Gottlieb S, Woodcock J. The FDA and the next wave of drug abuse — Proactive pharmacovigilance. N Engl J Med 2018;379:19 de julio. [Ref.ID 102679]
10.Enlace a cita original Cita con resumen
Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med 2018;378:22 de febrero. [Ref.ID 102557]
11. Cita con resumen
Anónimo. Opioid prescriptions fell 10 percent last year, report says . DIA Daily 2018:13. [Ref.ID 102519]
12. Cita con resumen
Darrow JJ, Avorn J, Kesselheim AS. The FDA breakthrough-drug designation - Four years of experience. N Engl J Med 2018;378:16 de abril. [Ref.ID 102515]
14. Cita con resumen
Anónimo. Outbreak Alert: Potential life-threatening vitamin K-dependent antagonist coagulopathy associated with synthetic cannabinoids use. Centers for Disease Control and Prevention 2018:5 de abril. [Ref.ID 102503]
15. Cita con resumen
Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the safety of opioid use for acute noncancer pain in hospitalized adults: a consensus statement from the Society of Hospital Medicine. J Hosp Med 2018;13:abril. [Ref.ID 102501]
16. Cita con resumen
18.Enlace a cita originalTiene citas relacionadas Cita con resumen
Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees . JAMA Intern Med 2018;178:673-9. [Ref.ID 102494]
19.Enlace a cita originalTiene citas relacionadas Cita con resumen
Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Intern Med 2018;178:667-72. [Ref.ID 102493]
20.Enlace a cita originalTiene citas relacionadas Cita con resumen
Hill KP, Saxon AJ. The role of cannabis legalization in the opioid crisis. JAMA Intern Med 2018;178:679-80. [Ref.ID 102492]
Seleccionar todas
 
 1 a 20 de 1059 siguiente >>